ISTA Pharmaceuticals (ISTA), announced that at the special meeting of ISTA stockholders held earlier, ISTA's stockholders voted to approve the adoption of the previously announced Agreement and Plan of Merger, dated March 26, as amended on May 24, by and among Bausch + Lomb Incorporated, Inga Acquisition Corporation, a wholly-owned subsidiary of Bausch & Lomb Incorporated, and ISTA. The affirmative vote of the holders of a majority of the outstanding shares of ISTA's common stock was required to approve the proposal to adopt the merger agreement. According to the final tally of shares voted, 78.5% of the outstanding shares of ISTA's common stock as of the close of business on April 23, the record date, were voted to approve the proposal to adopt the merger agreement. A quorum of 79.32% of ISTA's total outstanding shares of common stock as of the April 23 record date voted at the special meeting. The proposed merger was announced on March 26 and is expected to close on June 6.
America has no tolerance for wealthy people griping about their financial woes. But they have concerns too.